Inventor
HUANG BETTY
US14 patents
Patents
14 patentsUS6316223B1Nov 13, 2001
Mammalian protein interaction cloning system
RIGEL PHARMACEUTICALS INC29 citations92
US6114111ASep 5, 2000
Mammalian protein interaction cloning system
RIGEL PHARMACEUTICALS INC30 citations92
US6887675B1May 3, 2005
Tankyrase H, compositions involved in the cell cycle and methods of use
RIGEL PHARMACEUTICALS INC7 citations71
US6696263B1Feb 24, 2004
PCNA associated cell cycle proteins, compositions and methods of use
RIGEL PHARMACEUTICALS INC4 citations62
US6737232B1May 18, 2004
IAPs associated cell cycle proteins, compositions and methods of use
RIGEL PHARMACEUTICALS INC2 citations61
US6589725B1Jul 8, 2003
Tankyrase H, compositions involved in the cell cycle and methods of use
RIGEL PHARMACEUTICALS INC3 citations61
US6428980B1Aug 6, 2002
Nucleic acids encoding RIP3 associated cell cycle proteins
RIGEL PHARMACEUTICALS INC2 citations60
US7423118B1Sep 9, 2008
IAPS associated cell cycle proteins, compositions and methods of use
RIGEL PHARMACEUTICALS INC0 citations51
US7420045B1Sep 2, 2008
IAPs associated cell cycle proteins, compositions and methods of use
RIGEL PHARMACEUTICALS INC0 citations51
US6387658B1May 14, 2002
PCNA-associated cell cycle proteins, compositions and methods of use
RIGEL PHARMACEUTICALS INC1 citations51
US7488805B2Feb 10, 2009
Apoptosis proteins
RIGEL PHARMACEUTICALS INC0 citations50
US7223850B1May 29, 2007
Apoptosis proteins
RIGEL PHARMACEUTICALS INC0 citations50
US7001732B2Feb 21, 2006
RIP3 associated cell cycle protein
RIGEL PHARMACEUTICALS INC0 citations50
US6617102B1Sep 9, 2003
Tankyrase H, compositions involved in the cell cycle and methods of use
RIGEL PHARMACEUTICALS INC0 citations50